163 related articles for article (PubMed ID: 23512194)
41. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
[TBL] [Abstract][Full Text] [Related]
42. Bone lesions of multiple myeloma in three dogs.
Maeda H; Ozaki K; Abe T; Matsui H; Sano M; Narama I
Zentralbl Veterinarmed A; 1993 Jun; 40(5):384-92. PubMed ID: 8212953
[TBL] [Abstract][Full Text] [Related]
43. Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma.
Suntharalingam S; Mikat C; Wetter A; Guberina N; Salem A; Heil P; Forsting M; Nassenstein K
Eur Radiol; 2018 Jun; 28(6):2273-2280. PubMed ID: 29322333
[TBL] [Abstract][Full Text] [Related]
44. Bones in Multiple Myeloma: Imaging and Therapy.
Zamagni E; Cavo M; Fakhri B; Vij R; Roodman D
Am Soc Clin Oncol Educ Book; 2018 May; 38():638-646. PubMed ID: 30231385
[TBL] [Abstract][Full Text] [Related]
45. Scintigraphic evaluation of the skeleton in multiple myeloma.
Wahner HW; Kyle RA; Beabout JW
Mayo Clin Proc; 1980 Dec; 55(12):739-46. PubMed ID: 7218877
[TBL] [Abstract][Full Text] [Related]
46. Radiation dosimetry considerations for skeletal survey imaging of multiple myeloma.
Boyd C; Hickson K
Phys Med; 2019 Aug; 64():109-113. PubMed ID: 31515009
[TBL] [Abstract][Full Text] [Related]
47. Digital amorphous silicon flat-panel detector radiography at different exposure doses versus mammography film: possibility of radiation dose reduction in detecting rheumatologic bone defects.
Zähringer M; Reineck S; Perniok A; Krüger K; Andermahr J; Rubbert A; Winnekendonk G
Acta Radiol; 2008 Mar; 49(2):157-66. PubMed ID: 18300139
[TBL] [Abstract][Full Text] [Related]
48. Wide-volume versus helical acquisition in unenhanced chest CT: prospective intra-patient comparison of diagnostic accuracy and radiation dose in an ultra-low-dose setting.
Meyer E; Labani A; Schaeffer M; Jeung MY; Ludes C; Meyer A; Roy C; Leyendecker P; Ohana M
Eur Radiol; 2019 Dec; 29(12):6858-6866. PubMed ID: 31175414
[TBL] [Abstract][Full Text] [Related]
49. Bone scintigraphy in the diagnosis of skeletal involvement and metastatic calcification in multiple myeloma.
Nilsson-Ehle H; Holmdahl C; Suurküla M; Westin J
Acta Med Scand; 1982; 211(6):427-32. PubMed ID: 7113758
[TBL] [Abstract][Full Text] [Related]
50. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.
Kröpil P; Fenk R; Fritz LB; Blondin D; Kobbe G; Mödder U; Cohnen M
Eur Radiol; 2008 Jan; 18(1):51-8. PubMed ID: 17924119
[TBL] [Abstract][Full Text] [Related]
51. [Bone scintigraphy in multiple myeloma].
Valat JP; Eveleigh MC; Fouquet B; Born P
Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):707-11. PubMed ID: 4095476
[TBL] [Abstract][Full Text] [Related]
52. Association of QCT Bone Mineral Density and Bone Structure With Vertebral Fractures in Patients With Multiple Myeloma.
Borggrefe J; Giravent S; Thomsen F; Peña J; Campbell G; Wulff A; Günther A; Heller M; Glüer CC
J Bone Miner Res; 2015 Jul; 30(7):1329-37. PubMed ID: 25545497
[TBL] [Abstract][Full Text] [Related]
53. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.
Ghanem N; Lohrmann C; Engelhardt M; Pache G; Uhl M; Saueressig U; Kotter E; Langer M
Eur Radiol; 2006 May; 16(5):1005-14. PubMed ID: 16463030
[TBL] [Abstract][Full Text] [Related]
54. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
55. [Multiple myeloma: current recommendations for imaging].
Hillengass J; Delorme S
Radiologe; 2012 Apr; 52(4):360-5. PubMed ID: 22441560
[TBL] [Abstract][Full Text] [Related]
56. The evolving field of bone imaging in multiple myeloma: is it time to abandon skeletal surveys?
Mian HS; McCurdy A
Curr Oncol; 2020 Feb; 27(1):10-11. PubMed ID: 32218654
[No Abstract] [Full Text] [Related]
57. Dual-tracer PET/CT scan after injection of combined [
Withofs N; Beguin Y; Cousin F; Tancredi T; Simoni P; Alvarez-Miezentseva V; De Prijck B; Hafraoui K; Bonnet C; Baron F; Hustinx R; Caers J
Hematol Oncol; 2019 Apr; 37(2):193-201. PubMed ID: 30821017
[TBL] [Abstract][Full Text] [Related]
58. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Lütje S; de Rooy JW; Croockewit S; Koedam E; Oyen WJ; Raymakers RA
Ann Hematol; 2009 Dec; 88(12):1161-8. PubMed ID: 19763570
[TBL] [Abstract][Full Text] [Related]
59. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Raje N; Terpos E; Willenbacher W; Shimizu K; García-Sanz R; Durie B; Legieć W; Krejčí M; Laribi K; Zhu L; Cheng P; Warner D; Roodman GD
Lancet Oncol; 2018 Mar; 19(3):370-381. PubMed ID: 29429912
[TBL] [Abstract][Full Text] [Related]
60. Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma?
de Waal EG; Slart RH; Vellenga E
Clin Nucl Med; 2012 Oct; 37(10):939-42. PubMed ID: 22955067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
